Microbial Community Composition and Metabolism in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Cystic Fibrosis
Related studies linked through entity extraction aliases.
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation
- Status
- TERMINATED
- Phase
- PHASE2
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?
- Status
- COMPLETED
- Phase
- PHASE2
Natural History of Bronchiectasis
- Status
- RECRUITING
- Phase
- N/A
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo
- Status
- COMPLETED
- Phase
- PHASE3
Structure and Function of Salivary Proteins
- Status
- UNKNOWN
- Phase
- N/A
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients
- Status
- COMPLETED
- Phase
- N/A
Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients
- Status
- UNKNOWN
- Phase
- NA
28 Day Repeat Dose in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)
- Status
- COMPLETED
- Phase
- NA
A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
- Status
- COMPLETED
- Phase
- PHASE3
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
- Status
- COMPLETED
- Phase
- PHASE3
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
- Status
- COMPLETED
- Phase
- PHASE2